International Drug Development Institute – IDDI

Your Regulatory Statistics
& Clinical Data Science Partner

Your clinical trial data are your most valuable asset, deserving the highest standard of care.

Explore Our Services:

card icon

Strategic Consulting
card icon

Randomization and Trial Supply Management
card icon

Clinical Data Management
card icon

Biostatistics

Let IDDI be the guardian of your data, turning your clinical trials into a success. 

Contact Us

IDDI is the center of excellence in biostatistics and clinical data science with deep expertise in handling complex data challenges.  

At IDDI, we are not a traditional contract research organization (CRO); we are your dedicated clinical data partner, committed to excellence from clinical trial design to regulatory submission.

We offer regulatory statistics, clinical trial design, RTSM, clinical data management, and biostatistical services for pharmaceutical, biotech, and medical device/diagnostic companies.  

Therapeutic & Specialty Areas

With IDDI, drug development is powered by exceptional insights into cancer research, ophthalmology, CNS, and rare diseases combined with unmatched data quality acumen.

1,445+

Clinical Trials

350+

Customers Worldwide

30+

Years of Experience

Passion + Science + Experience = IDDI 

IDDI adds value to your clinical data with our:  

Global Reach

Offices in Europe and the USA so you have the right support where you need it.

Learn More

Scientific Team

Scientifically driven culture, strong collaborative approach with academics and key opinion leaders (KOLs), and commitment to data expertise ensure we stay at the leading edge of clinical practice.

Learn More

Clinical Trial Optimization

Driven by the passion to enhance the overall quality and efficiency of clinical trials, we provide tailored and efficient strategies for FDA-EMA submission, guaranteeing timely completion within budget constraints.

Learn More

Therapeutic Expertise

Offering a unique combination of methodological excellence, scientific expertise, and operational efficiency across multiple therapeutic areas — including oncology, ophthalmology, CNS, and rare diseases.

Learn More

Patient-Centric Services

At IDDI, we are dedicated to patient-centricity, which has driven the development of our Generalized Pairwise Comparisons (GPC) method. This innovative approach empowers clinicians to provide personalized treatments that align with the unique preferences and needs of each patient. In July 2023, this research culminated in the establishment of One2Treat, a new company focused on enhancing clinical trials.

One2Treat utilizes an innovative statistical method for the design and analysis of clinical trials, concentrating on multiple dimensions to ensure that all key patient-relevant outcomes are incorporated into treatment decisions, particularly in primary analyses.

Our commitment to patient-centric services is paving the way for more effective and tailored healthcare solutions.

Benefits:

  • Increased clinical relevance
  • Enhanced utilization of collected data
  • Clinical trial designs accommodating multiple endpoints
  • Reduced sample size

The Latest From IDDI

VIEW BY:
Blog

5 Proven Strategies to Improve Recruitment and Reduce Patient Dropout in Trials 

April 10, 2025
Blog

How the Oscars Reveal the Hidden Work Behind Successful Ophthalmology Clinical Trials – From Script to Screen (Part 2)

March 19, 2025
Blog

How the Oscars Reveal the Hidden Work Behind Successful Ophthalmology Clinical Trials – From Script to Screen (Part 1)

March 13, 2025

Trust Your Data to IDDI

Start Now